MAUDE Adverse Event Report: DAVIS & GECK CARIBE LTD CAPROSYN; SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC AC

Model Number	GC-122
Medical Device Problem Code	Break (1069)
Health Effect - Clinical Code	Insufficient Information (4580)
Date of Event	12/18/2023
Type of Reportable Event	Malfunction
Event or Problem Description
According to the reporter, during a veterinary procedure, it was noted that as soon as the customer took the 17 sutures out of the packaging, it tore immediately.
Additional Manufacturer Narrative
D10 concomitant products: gc-122, gc-122 caprosyn* 3-0 und 75cm v20 x36 (lot#d2e1153y) gc-122, gc-122 caprosyn* 3-0 und 75cm v20 x36 (lot#d2e1153y) gc-122, gc-122 caprosyn* 3-0 und 75cm v20 x36 (lot#d2e1153y) gc-122, gc-122 caprosyn* 3-0 und 75cm v20 x36 (lot#d2e1153y) gc-122, gc-122 caprosyn* 3-0 und 75cm v20 x36 (lot#d2e1153y) gc-122, gc-122 caprosyn* 3-0 und 75cm v20 x36 (lot#d2e1153y) gc-122, gc-122 caprosyn* 3-0 und 75cm v20 x36 (lot#d2e1153y) gc-122, gc-122 caprosyn* 3-0 und 75cm v20 x36 (lot#d2e1153y) gc-122, gc-122 caprosyn* 3-0 und 75cm v20 x36 (lot#d2e1153y) gc-122, gc-122 caprosyn* 3-0 und 75cm v20 x36 (lot#d2e1153y) gc-122, gc-122 caprosyn* 3-0 und 75cm v20 x36 (lot#d2e1153y) gc-122, gc-122 caprosyn* 3-0 und 75cm v20 x36 (lot#d2e1153y) gc-122, gc-122 caprosyn* 3-0 und 75cm v20 x36 (lot#d2e1153y) gc-122, gc-122 caprosyn* 3-0 und 75cm v20 x36 (lot#d2e1153y) gc-122, gc-122 caprosyn* 3-0 und 75cm v20 x36 (lot#d2e1153y) gc-122, gc-122 caprosyn* 3-0 und 75cm v20 x36 (lot#d2e1153y) gc-122, gc-122 caprosyn* 3-0 und 75cm v20 x36 (lot#d2e1153y) gc-122, gc-122 caprosyn* 3-0 und 75cm v20 x36 (lot#d2e1153y) gc-122, gc-122 caprosyn* 3-0 und 75cm v20 x36 (lot#d2e1153y) gc-122, gc-122 caprosyn* 3-0 und 75cm v20 x36 (lot#d2e1153y); medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
Additional Manufacturer Narrative
Additional information: b5, d9 (return date), g3, h6 (img code) medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
Event or Problem Description
According to the reporter, during a veterinary procedure, it was noted that as soon as the customer took the 18 sutures out of the packaging, it tore immediately.
Additional Manufacturer Narrative
H3 evaluation summary: medtronic conducted an investigation based upon all information received.Twenty sealed devices were available for evaluation.A tactile and microscopic inspection of one suture sample was performed.The suture broke as it was being removed from the retainer.The break site of the suture was 4 1/8 inches from the needle attachment point.The suture also frayed at the needle attachment point when taking the measurement.The breathable and foil pouches were inspected with light assisted microscopy with no abnormalities.It was reported that the suture was broken.The reported issue was confirmed.The most likely cause was determined to be manufacturing related.Internal process improvements have been initiated to mitigate this issue.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.

• Brand Name: CAPROSYN
• Common Device Name: SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC AC
• Manufacturer (Section D): DAVIS & GECK CARIBE LTD; zona franca de san isidro; santo domingo 0101 ; DR 0101
• Manufacturer (Section G): DAVIS & GECK CARIBE LTD; zona franca de san isidro; santo domingo 0101 ; DR 0101
• Manufacturer Contact: justin ellis ; 8200 coral sea st ne; mounds view, MN 55112 ; 7635265677
• MDR Report Key: 18697494
• Report Number: 9612501-2024-00410
• Device Sequence Number: 12830534
• Product Code: GAM
• UDI-Device Identifier: 10884521034426
• UDI-Public: 10884521034426
• Combination Product (Y/N): N
• Initial Reporter Country: GM
• PMA/510(K) Number: K032586
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Serviced by Third Party (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Foreign,Health Professional,Company Representative,Distributor
• Initial Reporter Occupation: Physician
• Type of Report: Initial,Followup,Followup
• Report Date (Section B): 12/10/2024

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 04/30/2025
• Device Model Number: GC-122
• Device Catalogue Number: GC-122
• Device Lot Number: D2E1153Y
• Was Device Available for Evaluation?: Device Returned to Manufacturer
• Date Returned to Manufacturer: 02/12/2024
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 01/23/2024
• Supplement Date Received by Manufacturer: 03/01/2024; 11/22/2024
• Initial Report FDA Received Date: 02/13/2024
• Supplement Report FDA Received Date: 03/27/2024; 12/10/2024
• Was Device Evaluated by Manufacturer? (Y/N): Yes
• Date Device Manufactured: 05/11/2022
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Patient Sex: Unknown